Nuclear medicine. Rosatom finished erecting a building frame for Europe’s largest radiopharmaceuticals factory. The factory is being built on the premises of the Karpov Institute of Physical Chemistry (part of Rosatom) in Obninsk (Kaluga Region). Rosatom’s current product range includes 11 radiopharmaceuticals. The radioisotopes produced by the Russian nuclear corporation allow for about one million diagnostic and therapeutic procedures to be performed in Russia every year. After the factory is put into operation in 2025, 21 production lines will manufacture up to 25 radiopharmaceutical substances. Rosatom researchers work together with clinicians in developing innovative drugs. “We are planning to pilot the production of encapsulated iodine in March 2024 and complete pre-clinical studies on a thorium-based drug in June 2024. Another innovative drug containing lutetium has been already used to successfully treat the first patients,” says Igor Obrubov, Head of Rosatom’s Healthcare Technology division.